China Isotope & Radiation (HKSE:01763) Interest Expense : HK$-40 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is China Isotope & Radiation Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. China Isotope & Radiation's interest expense for the six months ended in Dec. 2023 was HK$ -23 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-40 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. China Isotope & Radiation's Operating Income for the six months ended in Dec. 2023 was HK$ 505 Mil. China Isotope & Radiation's Interest Expense for the six months ended in Dec. 2023 was HK$ -23 Mil. China Isotope & Radiation's Interest Coverage for the quarter that ended in Dec. 2023 was 22.16. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

China Isotope & Radiation Interest Expense Historical Data

The historical data trend for China Isotope & Radiation's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Isotope & Radiation Interest Expense Chart

China Isotope & Radiation Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-20.87

-41.46

-43.84

-39.46

-39.53

China Isotope & Radiation Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial											-23.17	-20.34	-20.09	-16.73	-22.80

China Isotope & Radiation Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-40 Mil.

China Isotope & Radiation (HKSE:01763) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

China Isotope & Radiation's Interest Expense for the six months ended in Dec. 2023 was HK$-23 Mil. Its Operating Income for the six months ended in Dec. 2023 was HK$505 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was HK$1,617 Mil.

China Isotope & Radiation's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	505.25	/	-22.804
	=	22.16

The higher the ratio, the stronger the company's financial strength is.

China Isotope & Radiation (HKSE:01763) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » China Isotope & Radiation Corp (HKSE:01763) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 66 Changwa Middle Street, Haidian District, Beijing, CHN, 100089

Website

https://www.china-isotope.com

China Isotope & Radiation Corp is a Chinese company. It has five operating segments: Pharmaceuticals; Radioactive source products; Irradiation; Radiation therapy equipment and related services and Other businesses. Its Pharmaceutical segment is the key revenue driver, which manufactures and sells imaging diagnostic and therapeutic radiopharmaceuticals imaging, UBT diagnostic kits, and test analyzers, and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The Group's operations are carried out and majority of the Group's customers are located in the PRC.

Executives

Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Ubs Group Ag	2201 Interest of corporation controlled by you
Li Hongbo	2201 Interest of corporation controlled by you
Lianwen Ltd	2101 Beneficial owner
Invesco Advisers, Inc.	2102 Investment manager
The Bank Of New York Mellon Corporation	2201 Interest of corporation controlled by you
Invesco Hong Kong Limited	2102 Investment manager
Invesco Corporate Class Inc.	2106 Person having a security interest in shares
M&g Plc	2201 Interest of corporation controlled by you
Shanghai Industrial Holdings Limited	2201 Interest of corporation controlled by you
Shanghai Industrial Investment (holdings) Company Limited	2201 Interest of corporation controlled by you
Serenity Investment Master Fund Limited	2101 Beneficial owner
Serenity Capital Management, Ltd.	2102 Investment manager
Shanghai Pharmaceuticals Holding Co., Ltd.	2201 Interest of corporation controlled by you
S.i. Infrastructure Holdings Limited	2201 Interest of corporation controlled by you

China Isotope & Radiation (HKSE:01763) Headlines

No Headlines